Shenzhen Sinobio Biopharmaceutical
Latest round
- Angel
Last raised
- May 2025
Total raised
- Undisclosed
Investors
- 3
About Shenzhen Sinobio Biopharmaceutical
Founded in 2024 and based in Shenzhen, China, Shenzhen Sinobio Biopharmaceutical operates as a biotechnology service provider focusing on the research and development of recombinant botulinum toxin. Shenzhen Sinobio Biopharmaceutical has an exclusive green preparation process for synthetic biology-botulinum toxin, an AI botulinum protein design and directed evolution platform, a botulinum protein function high-throughput screening platform, and a number of independent recombinant botulinum toxin core technologies.
Who invested in Shenzhen Sinobio Biopharmaceutical
3 investors across 1 round
See all investors in Shenzhen Sinobio Biopharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 24, 2025
Amount
Undisclosed
Investors
Questions about Shenzhen Sinobio Biopharmaceutical
Who invested in Shenzhen Sinobio Biopharmaceutical?
Shenzhen Sinobio Biopharmaceutical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Sinobio Biopharmaceutical raised?
Shenzhen Sinobio Biopharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shenzhen Sinobio Biopharmaceutical last raise money?
Shenzhen Sinobio Biopharmaceutical's most recent round on record is a Angel, in May 2025.
What does Shenzhen Sinobio Biopharmaceutical do?
Founded in 2024 and based in Shenzhen, China, Shenzhen Sinobio Biopharmaceutical operates as a biotechnology service provider focusing on the research and development of recombinant botulinum toxin.
Where is Shenzhen Sinobio Biopharmaceutical headquartered?
Shenzhen Sinobio Biopharmaceutical is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Sinobio Biopharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Shenzhen Sinobio Biopharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Shenzhen Sinobio Biopharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.